Lupus I Flashcards
Characteristic marker of SLE
Anti-nucleic acid autoantibodies (ANAs)
Rates of SLE have ___ in the past 40 years
Rates of SLE have more than tripled in the past 40 years
The gender ratio for SLE is __:__ female:male
The gender ratio for SLE is 9:1 female:male
Suggested reasons for gender preference in SLE
- Role of estrogen in disease
- X-linked genes associated with risk
Onset of lupus
Anywhere from ~10 to 55 years, mean age in 30’s
Common causes of mortality in Lupus patients
- Cardiovascular disease
- Renal failure
- Infection
Typical treatments for Lupus
- Corticosteroids
- Other immunosuppressants (cyclophosphamide, etc)
- Antimalarials
- Appropriate treatment of comorbidities
__ of __ criteria are needed for the diagnosis of SLE.
4 of 11 criteria are needed for the diagnosis of SLE.
Genes which predispose to SLE
- C1q and C4 (complement)
- Lack of C4 functionality leads to decreased elimination of autoimmune B cells
- Lack of C1q functionality leads to decreased clearance of necrotic debris
- CD40 (necessary for B cell longevity and class-switching)
- Fc receptors (variants which bind to Igs poorly and make ICs harder to clear)
- Type I IFN variants
Criterion table for SLE
SLE patients have very high baseline levels of serum ___.
SLE patients have very high baseline levels of serum Type I IFNs.
Although the spectrum of autoantibody specificities in SLE is ___, only a few have ___.
Although the spectrum of autoantibody specificities in SLE is extensive, only a few have been shown to contribute to disease-related tissue injury.
Anti-CD3 and Anti-TCR
- Suppress IL-2 production
- Poor T cell proliferation results
Anti-DNA, anti-histone, and anti-chromatin
- Main drivers of immune complex formation in SLE
- Result commonly in kidney disease and neuropathy
Anti-Ro antibodies
- Alter function of myocytes and cells in the conduction system of the heart
- Linked to neonatal Lupus and congenital heart block
Anti-NMDAR antibodies
- Often a result of cross-reactivity due to NMDAR and DNA similarities
- NMDAR is expressed on CNS neurons, and so this antibody in CSF may lead to CNS neuropathy and cognitive deficits
- Resulting inflammation also compromises the blood-brain barrier